Skip to content
WeighLab
Menu
Ranked #148 · Grade C

NexLife review

NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

Visit NexLife Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$165/mo (compounded)
Tirzepatide
$215/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$1,980

Tirzepatide · modeled / year

$2,580

The Index scorecard

NexLife scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month72/100
Price Transparency86/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight88/100
Contract Flexibility55/100

Where the value is

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

The tradeoffs

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

The bottom line

Best for: Cost-first shoppers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

Ranked #148 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NexLife.

The 19 programs nearest this one

Pricing, states and verification reflect NexLife's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NexLife's site. Not medical advice; see our disclosure.

← Back to the value leaderboard